Study: Biotech no riskier for investors January 21, 2021 Auto Bot BioPharma, biotech IPO, Massachusetts, News, Startups 0 Despite lower sales, lack of profits and heavy R&D spending, biotech companies that went public between 1997 and 2016 reached similar market caps as non-biotech companies, according to an academic study.